vs

Side-by-side financial comparison of STEPAN CO (SCL) and INNOVATE Corp. (VATE). Click either name above to swap in a different company.

STEPAN CO is the larger business by last-quarter revenue ($604.5M vs $382.7M, roughly 1.6× INNOVATE Corp.). STEPAN CO runs the higher net margin — 3.3% vs -1.9%, a 5.2% gap on every dollar of revenue. On growth, INNOVATE Corp. posted the faster year-over-year revenue change (61.7% vs 1.9%). Over the past eight quarters, INNOVATE Corp.'s revenue compounded faster (10.2% CAGR vs 4.2%).

Stepan Company is an American manufacturer of specialty chemicals headquartered in Northbrook, Illinois. The company was founded in 1932 by Alfred C. Stepan, Jr., and has approximately 2,000 employees. It is currently run by his grandson, F. Quinn Stepan, Jr. The company describes itself as the largest global merchant manufacturer of anionic surfactants, which are used to enhance the foaming and cleaning capabilities of detergents, shampoos, toothpastes, and cosmetics.

Innovate Corp. is an American public financial services company founded in 1994.

SCL vs VATE — Head-to-Head

Bigger by revenue
SCL
SCL
1.6× larger
SCL
$604.5M
$382.7M
VATE
Growing faster (revenue YoY)
VATE
VATE
+59.9% gap
VATE
61.7%
1.9%
SCL
Higher net margin
SCL
SCL
5.2% more per $
SCL
3.3%
-1.9%
VATE
Faster 2-yr revenue CAGR
VATE
VATE
Annualised
VATE
10.2%
4.2%
SCL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
SCL
SCL
VATE
VATE
Revenue
$604.5M
$382.7M
Net Profit
$19.7M
$-7.4M
Gross Margin
10.7%
15.4%
Operating Margin
4.7%
3.7%
Net Margin
3.3%
-1.9%
Revenue YoY
1.9%
61.7%
Net Profit YoY
55.4%
EPS (diluted)
$0.86
$-0.57

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
SCL
SCL
VATE
VATE
Q1 26
$604.5M
Q4 25
$553.9M
$382.7M
Q3 25
$590.3M
$347.1M
Q2 25
$594.7M
$242.0M
Q1 25
$593.3M
$274.2M
Q4 24
$525.6M
$236.6M
Q3 24
$546.8M
$242.2M
Q2 24
$556.4M
$313.1M
Net Profit
SCL
SCL
VATE
VATE
Q1 26
$19.7M
Q4 25
$5.0M
$-7.4M
Q3 25
$10.8M
$-8.9M
Q2 25
$11.3M
$-19.8M
Q1 25
$19.7M
$-24.5M
Q4 24
$3.4M
$-16.6M
Q3 24
$23.6M
$-15.0M
Q2 24
$9.5M
$14.4M
Gross Margin
SCL
SCL
VATE
VATE
Q1 26
10.7%
Q4 25
9.3%
15.4%
Q3 25
12.0%
14.3%
Q2 25
12.1%
18.8%
Q1 25
12.7%
16.6%
Q4 24
10.8%
19.6%
Q3 24
13.8%
19.9%
Q2 24
12.5%
21.0%
Operating Margin
SCL
SCL
VATE
VATE
Q1 26
4.7%
Q4 25
1.9%
3.7%
Q3 25
3.7%
1.8%
Q2 25
3.0%
2.0%
Q1 25
4.8%
1.2%
Q4 24
1.5%
1.1%
Q3 24
4.4%
2.4%
Q2 24
3.4%
9.2%
Net Margin
SCL
SCL
VATE
VATE
Q1 26
3.3%
Q4 25
0.9%
-1.9%
Q3 25
1.8%
-2.6%
Q2 25
1.9%
-8.2%
Q1 25
3.3%
-8.9%
Q4 24
0.6%
-7.0%
Q3 24
4.3%
-6.2%
Q2 24
1.7%
4.6%
EPS (diluted)
SCL
SCL
VATE
VATE
Q1 26
$0.86
Q4 25
$0.22
$-0.57
Q3 25
$0.47
$-0.71
Q2 25
$0.50
$-1.67
Q1 25
$0.86
$-1.89
Q4 24
$0.14
$-0.72
Q3 24
$1.03
$-1.18
Q2 24
$0.42
$1.03

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
SCL
SCL
VATE
VATE
Cash + ST InvestmentsLiquidity on hand
$112.1M
Total DebtLower is stronger
$328.4M
$80.3M
Stockholders' EquityBook value
$1.2B
$-240.1M
Total Assets
$2.3B
$950.1M
Debt / EquityLower = less leverage
0.28×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
SCL
SCL
VATE
VATE
Q1 26
Q4 25
$132.7M
$112.1M
Q3 25
$118.5M
$35.5M
Q2 25
$88.9M
$33.4M
Q1 25
$107.5M
$33.3M
Q4 24
$99.7M
$48.8M
Q3 24
$147.3M
$51.0M
Q2 24
$124.7M
$80.2M
Total Debt
SCL
SCL
VATE
VATE
Q1 26
$328.4M
Q4 25
$626.7M
$80.3M
Q3 25
$655.5M
$97.3M
Q2 25
$658.0M
$160.1M
Q1 25
$659.3M
$139.9M
Q4 24
$625.4M
$500.6M
Q3 24
$688.5M
$502.4M
Q2 24
$657.1M
$638.3M
Stockholders' Equity
SCL
SCL
VATE
VATE
Q1 26
$1.2B
Q4 25
$1.2B
$-240.1M
Q3 25
$1.2B
$-233.3M
Q2 25
$1.2B
$-224.8M
Q1 25
$1.2B
$-204.2M
Q4 24
$1.2B
$-180.4M
Q3 24
$1.2B
$-163.1M
Q2 24
$1.2B
$-149.0M
Total Assets
SCL
SCL
VATE
VATE
Q1 26
$2.3B
Q4 25
$2.4B
$950.1M
Q3 25
$2.4B
$913.2M
Q2 25
$2.4B
$890.9M
Q1 25
$2.4B
$868.0M
Q4 24
$2.3B
$891.1M
Q3 24
$2.4B
$897.2M
Q2 24
$2.3B
$898.9M
Debt / Equity
SCL
SCL
VATE
VATE
Q1 26
0.28×
Q4 25
0.50×
Q3 25
0.53×
Q2 25
0.53×
Q1 25
0.55×
Q4 24
0.53×
Q3 24
0.56×
Q2 24
0.55×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
SCL
SCL
VATE
VATE
Operating Cash FlowLast quarter
$101.1M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
SCL
SCL
VATE
VATE
Q1 26
Q4 25
$60.0M
$101.1M
Q3 25
$69.8M
$19.2M
Q2 25
$11.2M
$40.4M
Q1 25
$6.9M
$-14.1M
Q4 24
$68.3M
$41.4M
Q3 24
$22.7M
$-28.4M
Q2 24
$29.5M
$21.5M
Free Cash Flow
SCL
SCL
VATE
VATE
Q1 26
Q4 25
$25.4M
Q3 25
$40.2M
$19.0M
Q2 25
$-14.4M
Q1 25
$-25.8M
$-18.8M
Q4 24
$32.1M
$34.2M
Q3 24
$-4.0M
$-31.5M
Q2 24
$-208.0K
$18.4M
FCF Margin
SCL
SCL
VATE
VATE
Q1 26
Q4 25
4.6%
Q3 25
6.8%
5.5%
Q2 25
-2.4%
Q1 25
-4.3%
-6.9%
Q4 24
6.1%
14.5%
Q3 24
-0.7%
-13.0%
Q2 24
-0.0%
5.9%
Capex Intensity
SCL
SCL
VATE
VATE
Q1 26
Q4 25
6.3%
Q3 25
5.0%
0.1%
Q2 25
4.3%
Q1 25
5.5%
1.7%
Q4 24
6.9%
3.0%
Q3 24
4.9%
1.3%
Q2 24
5.3%
1.0%
Cash Conversion
SCL
SCL
VATE
VATE
Q1 26
Q4 25
11.99×
Q3 25
6.44×
Q2 25
0.99×
Q1 25
0.35×
Q4 24
20.38×
Q3 24
0.96×
Q2 24
3.10×
1.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

SCL
SCL

Surfactants$453.7M75%
Polymers$130.0M22%
Specialty Products$20.8M3%

VATE
VATE

Commercial Revenue$126.1M33%
Industrial Revenue$87.5M23%
Transportation Revenue$58.4M15%
Healthcare Revenue$48.4M13%
Government Revenue$44.3M12%
Energy Revenue$8.0M2%
Broadcast Station Revenue$5.7M1%
Systems And Consumables Revenue$3.1M1%
Leisure Revenue$200.0K0%

Related Comparisons